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Abstract
Long-term potentiation (LTP) at hippocampal CA3–CA1 synapses is thought to be mediated, at least in part, by an increase in the
postsynaptic surface expression of a-amino-3-hydroxy-5-methyl-4-isoxazole proprionic acid (AMPA) receptors induced by N-methyl-
d-aspartate (NMDA) receptor activation. While this process was originally attributed to the regulated synaptic insertion of GluA1
(GluR-A) subunit-containing AMPA receptors, recent evidence suggests that regulated synaptic trafﬁcking of GluA2 subunits might
also contribute to one or several phases of potentiation. However, it has so far been difﬁcult to separate these two mechanisms
experimentally. Here we used genetically modiﬁed mice lacking the GluA1 subunit (Gria1
) ⁄ ) mice) to investigate GluA1-independent
mechanisms of LTP at CA3–CA1 synapses in transverse hippocampal slices. An extracellular, paired theta-burst stimulation
paradigm induced a robust GluA1-independent form of LTP lacking the early, rapidly decaying component characteristic of LTP in
wild-type mice. This GluA1-independent form of LTP was attenuated by inhibitors of neuronal nitric oxide synthase and protein kinase
C (PKC), two enzymes known to regulate GluA2 surface expression. Furthermore, the induction of GluA1-independent potentiation
required the activation of GluN2B (NR2B) subunit-containing NMDA receptors. Our ﬁndings support and extend the evidence that
LTP at hippocampal CA3–CA1 synapses comprises a rapidly decaying, GluA1-dependent component and a more sustained, GluA1-
independent component, induced and expressed via a separate mechanism involving GluN2B-containing NMDA receptors, neuronal
nitric oxide synthase and PKC.
Introduction
An eagerly discussed question in neuroscience is whether long-term
potentiation (LTP; Bliss & Lømo, 1973; Bliss & Collingridge, 1993)
engages the same neural mechanisms that are responsible for learning
and memory (Martin et al., 2000; Martin & Morris, 2002). However,
the complex mechanisms underlying LTP are still not completely
understood. Conventional hippocampal CA3–CA1 LTP (Bliss &
Collingridge, 1993) is believed to be expressed, at least in part, by an
increase in synaptic a-amino-3-hydroxy-5-methyl-4-isoxazole propr-
ionic acid (AMPA) receptors (AMPAR). Most AMPAR in hippocam-
pal neurons are heterodimers composed of either GluA1⁄GluA2 or
GluA2⁄GluA3 subunit combinations (Wenthold et al., 1996), using
the new subunit nomenclature recommended by the International
Union of Basic and Clinical Pharmacology (IUPHAR). Accordingly,
AMPAR subunits earlier known as either GluR-A, B, C and D, or
GluR1, 2, 3 and 4, are renamed GluA1, GluA2, GluA3 and GluA4,
and the corresponding mouse genes are Gria1, Gria2, Gria3 and
Gria4 (Collingridge et al., 2009). In an inﬂuential study, Shi et al.
(2001) suggested that LTP is mediated by an activity-regulated
increase in synaptic GluA1-containing AMPAR. Consistent with this
suggestion, Zamanillo et al. (1999) reported that LTP is absent in
Gria1
) ⁄ ) mice and concluded that the GluA1 subunit is an absolute
requirement for tetanus-induced CA3–CA1 LTP.
In contrast to GluA1⁄GluA2 AMPAR, GluA2⁄GluA3 AMPAR are
thought to constitutively cycle in and out of the synapse (Shi et al.,
2001). However, increasing evidence suggests that the constitutive
recycling of GluA2-containing AMPAR might not be that passive after
all: Daw et al. (2000) found that GluA2 surface expression is regulated
by a protein kinase C (PKC)-dependent mechanism, and regulated
insertion of GluA2 might be critical for the longer-term expression and
maintenance of LTP in the hippocampus (Gardner et al., 2005; Sossa
et al., 2007; Yao et al., 2008). Furthermore, activity-driven GluA2
insertion mediates a form of LTP in the cerebellum (Kakegawa &
Yuzaki, 2005), where the increase of GluA2-containing AMPAR is
regulated by nitric oxide (Huang et al., 2005), produced by neuronal
nitric oxide synthase (nNOS) upon N-methyl-d-aspartate (NMDA)
receptor (NMDAR) activation (Bredt & Snyder, 1989; Garthwaite
et al., 1989; Brenman & Bredt, 1997). A similar, nitric oxide-regulated
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hippocampal neurons (Sossa et al., 2006, 2007). Moreover, Hoffman
et al. (2002) provided initial evidence that hippocampal LTP can be
expressed without the GluA1 subunit: a theta-burst induction
paradigm revealed a gradually developing form of LTP in Gria1
) ⁄ )
mice. However, the precise mechanisms underlying this GluA1-
independent form of hippocampal LTP remained unclear.
We used extracellular ﬁeld recordings from hippocampal slices of
Gria1
) ⁄ )mice(Zamanilloetal.,1999)tostudythecellularmechanisms
of GluA1-independent CA3–CA1 LTP.Extracellular, paired theta-burst
stimulation induced robust LTP in Gria1
) ⁄ ) mice without the early,
rapidly decaying component characteristic of LTP in wild-type mice.
Induction of GluA1-independent LTP speciﬁcally required the GluN2B
(NR2B) NMDAR subunit. Moreover, GluA1-independent LTP was
abolishedbyinhibitorsofnNOSandPKC,twoenzymesthatparticipate
in the activity-regulated insertion of GluA2-containing AMPAR (Daw
et al., 2000; Perez et al., 2001; Huang et al., 2005; Sossa et al., 2006,
2007). Our data extend the evidence that CA3–CA1 LTP comprises a
rapidly decaying, GluA1-dependent phase and a more sustained,
GluA1-independent phase induced and expressed through a separate,
GluN2B-, nNOS- and PKC-dependent mechanism.
Materials and methods
Mice
All animal care and procedures described below were in compliance
with the UK Home Ofﬁce Project and Personal licenses held by the
authors in accordance with Home Ofﬁce regulations under the
Animals (Scientiﬁc Procedures) Act of 1986.
Gria1
) ⁄ ) mice were created on a hybrid C57BL⁄6⁄129sv back-
ground (Zamanillo et al., 1999). Several Gria1
) ⁄ ) breeding pairs
(> F4) were transported to the UK and backcrossed to C57BL⁄6. For
experimental cohorts of wild-type and Gria1
) ⁄ ) mice, Gria1
+ ⁄ ) mice
were intercrossed on-site in the departmental animal holding facility.
Mice were housed in groups of two–six with ad libitum access to food
and water on a 12 : 12 h dark : light cycle at a temperature of 22  C
and a humidity of 60–70%. For the following experiments, only male
mice were used to avoid variations due to physiological differences
between sexes.
Slice preparation
Horizontal hippocampal slices (350 lm) were prepared from adult
male Gria1
) ⁄ ) mice of at least 6 months of age and their male wild-
type littermates, after decapitation following isoﬂurane-induced
anaesthesia (Isocare, Animalcare, York, UK) in a desiccator (0.5 mL
isoﬂurane, until breathing slowed down to approximately one breath
per second, and stimulation of the limb withdrawal reﬂex no longer
elicited a response). Slices were stored at 34  C in an interface
recording chamber, and superfused (2 mL⁄min) with artiﬁcial cere-
brospinal ﬂuid (aCSF) of the following composition (in mm): NaCl,
126; KCl, 3; NaH2PO4, 1.25; MgSO4, 2; CaCl2, 2; NaHCO3, 26;
glucose, 10; bubbled with carbogen gas (95% O2–5% CO2)t op H
7.2–7.4.
Electrophysiological protocols
Extracellular ﬁeld recordings from CA1 were made with an
Axoclamp-2A ampliﬁer (Axon Instruments, Union City, CA, USA)
in bridge mode. Glass recording electrodes were pulled from standard
wall borosilicate tubing (4–6 MX) and ﬁlled with aCSF. Recording
and stimulation electrodes were positioned in CA1 with the aid of a
stereoscope (Fig. 1A).
Blind patch-clamp recordings (Castan ˜eda-Castellanos et al., 2006)
were made from CA1 pyramidal neurons with a Multiclamp 700B
ampliﬁer (Axon Instruments) in current-clamp mode. Patch pipettes
(6–8 MX) were pulled from standard wall borosilicate tubing and
ﬁlled with a solution containing (in mm): potassium gluconate, 110;
HEPES, 40; NaCl, 4; ATP-Mg, 4; biocytin; GTP, 0.3; pH 7.2–7.3. The
patch pipette was positioned just above the surface of the pyramidal
cell layer of CA1 under visual guidance and then slowly lowered
while constantly monitoring the current during voltage-clamp, in
response to a test voltage step. Once whole-cell conﬁguration was
achieved, cells were recorded in current-clamp. Pyramidal neurons
were identiﬁed according to their ﬁring pattern and by biocytin
labelling after the experiment, following standard procedures as
described by Oren et al. (2006).
Synaptic efﬁcacy was monitored in two independent afferent
Schaffer collateral pathways stimulated alternately, each at 0.1 Hz
(50 ls, 10–100 lA), with monopolar tungsten electrodes placed either
side of the recording electrode (Fig. 1A). For ﬁeld recordings, a
stimulus–response curve [10–100 lA stimulation strength, mean of
ﬁve ﬁeld excitatory postsynaptic potentials (fEPSPs) at each stimu-
lation strength] was established and the stimulation strength subse-
quently set to elicit an fEPSP of half-maximal amplitude in wild-type
mice and the corresponding amplitude in Gria1
) ⁄ ) mice (70% of the
half-maximal amplitude; Fig. 2B). The basal stimulation strength
during whole-cell recording from individual pyramidal neurons was
adjusted to evoke an EPSP peak amplitude of 5–10 mV in both
genotypes. fEPSP or EPSP rising slopes (middle third of the rising
phase, before the action potential threshold) were monitored for a
baseline period of 20 min. If synaptic transmission was stable (< 20%
change in fEPSP or EPSP slopes over 20 min), one of the two
A
B
Fig. 1. Position of electrodes and LTP induction paradigm. (A) Diagram of a
transverse hippocampal slice showing the position of stimulation and recording
electrodes. (B) Schematic illustration of the paired theta-burst stimulation
(pTBS) LTP induction paradigm.
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(100 Hz for 1 s) or paired theta-burst LTP induction paradigm
(Fig. 1B). The other pathway served as a control and was not
stimulated during the induction protocol. For paired theta-burst
stimulation, the intensity of the stimulus delivered through the third
electrode in the alveus was adjusted to a level just sufﬁcient to elicit an
antidromic population spike at the recording site.
In order to measure paired-pulse ratio (PPR), two 50-ls pulses with
an inter-pulse interval of 40 ms were given at a stimulation strength
eliciting half-maximal fEPSP amplitude in response to the ﬁrst
stimulus. The protocol was repeated ﬁve times at 0.1 Hz.
Pharmacology
Drugs were applied to the superfusate for at least 30 min (at least 1 h
for intracellularly acting drugs) before the onset of baseline recording.
To block NMDAR irrespective of GluN2 subunit composition, 30 lm
3-(R-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP; Tocris
Biosciences, Bristol, UK) was applied to the superfusate.
GluN2B-containing NMDAR were targeted by the ifenprodil-deriv-
ative (aR,bS)-a-(5-hydroxyphenyl)-b-methyl-4-(phenylmethyl)-1-pip-
eridinepropanol (Ro 25-6981; Tocris; Fischer et al., 1997), whereas
(R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahy-
droquinoxalin-5-yl)-methyl-phosphonic acid (NVP-AAM077; kindly
provided by Dr Y. Auberson, Novartis AG, Switzerland; Auberson
et al., 2002) was used to inhibit GluN2A-containing NMDA receptors.
To block Ca
2+⁄calmodulin-dependent protein kinase (CaM kinase),
1 lm 4-[(2S)-2-[(5-isoquinolinylsulphonyl) methylamino]-3-oxo-3-(4-
phenyl-1-piperazinyl)propyl] phenylisoquinolinesulphonic acid ester
(KN-62; Tocris; Tokumitsu et al., 1990) was added to the superfusate.
PKC was inhibited using 2 lm 1,2-dimethoxy-12-methyl[1,3]benzo-
dioxolo[5,6-c]phenanthridinium (chelerythrine; Tocris; Herbert et al.,
1990), which shows some selectivity for the atypical isoform protein
kinase Mf (PKMf) over other PKC isoforms at this concentration
(Ling et al., 2002). To inhibit nNOS, either 100 lm of the membrane-
permeable inhibitor (4S)-N-(4-amino-5[aminoethyl]aminopentyl)-
N¢-nitroguanidine (nNOS inhibitor I; Merck Biosciences, Nottingham,
UK; Hah et al., 2001) or 0.2 lm of vinyl-L-N-5-(1-imino-3-butenyl)-
L-ornithine (L-VNIO; Alexis, Nottingham, UK), another NOS
inhibitor with a high selectivity for nNOS (Hopper & Garthwaite,
2006), were applied to the aCSF. Unlike other drugs, nNOS inhibitors
were added to the aCSF during dissection, slice preparation and
throughout the recovery period in order to allow sufﬁcient time for the
drug to reach its intracellular target.
Data analysis
DataacquisitionandsubsequentanalysiswereperformedusingIgorPro
(WaveMetrics, Lake Oswego, OR, USA), and statistical analysis was
performed using spss software (SPSS, Chicago, IL, USA). Changes in
synaptic efﬁcacy were estimated by using the mean fEPSP or EPSP
risingslopesofaspeciﬁed5-minperiodexpressedasapercentageofthe
mean fEPSP or EPSP rising slope from the 5-min baseline period
immediatelybeforetheLTPinductionparadigmwasdelivered.PPRwas
expressedasthemeanratiooftherisingslopeofthesecondfEPSPtothe
rising slope of the ﬁrst fEPSP in % (average of ﬁve paired pulses). All
values are given as mean ± SEM, and statistical signiﬁcance was
assessed using the Student’s two-tailed t-test, anova and repeated-
measures (RM) anova, followed by a post hoc analysis of simple main
effects where applicable, using Sidak’s adjustments for multiple
comparisons. Numbers (n) refer to the number of mice.
A
B
C
Fig. 2. Synaptic transmission in Gria1
) ⁄ ) mice. (A) Representative CA1 ﬁeld
excitatory postsynaptic potentials (EPSPs) in slices from a wild-type mouse
(top left) and a Gria1
) ⁄ ) mouse (bottom left), and mean presynaptic ﬁbre
volley (pv) and fEPSP amplitudes elicited by a single rectangular current pulse
(50 lsa t7 0lA) in the stratum radiatum among the Schaffer collaterals (wild-
type, n = 13; Gria1
) ⁄ ), n = 21), ***P < 0.001 (anova). (B) Stimulation
strength–response curves for wild-type (n = 24) and Gria1
) ⁄ ) mice (n = 26).
To compensate for reduced synaptic transmission in Gria1
) ⁄ ) mice, the
baseline stimulation strength for wild-type and Gria1
) ⁄ ) mice in subsequent
experiments was set to elicit an fEPSP of 50% and 70% of the maximal fEPSP
amplitude, respectively. (C) Example traces of paired-pulse responses (left,
40-ms stimulus interval) and mean PPR in wild-type (n = 6) and Gria1
) ⁄ )
mice (n = 5). Data are presented as mean ± SEM.
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Gria1
) ⁄ ) mice show attenuated synaptic transmission
at CA3–CA1 synapses
To compare synaptic transmission at CA3–CA1 synapses in Gria1
) ⁄ )
and wild-type mice, extracellular ﬁeld recordings from the stratum
radiatum of CA1 were made while stimulating the Schaffer collateral
pathway with 50-ls current pulses at various amplitudes. In response
to single 70-lA current pulses, the mean fEPSP in Gria1
) ⁄ ) mice
reached only 65% of the mean fEPSP amplitude in wild-type mice
(Fig. 2A; one-way anova, F1,32 = 19.6, P < 0.001). The smaller
fEPSP amplitudes in Gria1
) ⁄ ) mice were observed across a range of
stimulation strengths from 10 to 100 lA (Fig. 2B; RM anova, main
effect of genotype F1,48 = 11.7, P<0.005, genotype by stimulation
strength interaction F9,432 = 5.8, P<0.05). The smaller fEPSP
amplitude in Gria1
) ⁄ ) mice could not be attributed to a reduction
in ﬁbre excitability, as the presynaptic ﬁbre volley amplitudes were
almost identical between the genotypes (Fig. 2A; one-way anova,
F<1). Moreover, a comparison of PPRs in wild-type and Gria1
) ⁄ )
mice showed no signiﬁcant differences between genotypes and thus
provided no evidence for an alteration of presynaptic signalling in
Gria1
) ⁄ ) mice (Fig. 2C; stimulus duration 50 ls, inter-stimulus
interval 40 ms, at 70 lA, one-way anova of PPR, F < 1; see also
Zamanillo et al., 1999). Hence, with equivalent presynaptic activation,
the postsynaptic response was signiﬁcantly smaller in Gria1
) ⁄ ) mice.
This result suggests that a higher stimulation strength is needed to
produce a postsynaptic excitatory current in Gria1
) ⁄ ) mice equivalent
to that in wild-type mice. In the following experiments, the stimulation
strength for monitoring basal synaptic transmission and for induction
of LTP in Gria1
) ⁄ ) mice was therefore set to 70% of the maximal
amplitude, roughly corresponding to 50% of the maximal amplitude in
wild-type mice (Fig. 2B).
Extracellular paired theta-burst stimulation induces a robust
GluA1-independent form of LTP
To induce CA3–CA1 LTP in Gria1
) ⁄ ) mice, we adapted the
intracellular theta-burst paradigm previously described by Hoffman
et al. (2002) for extracellular ﬁeld recordings. After stable baseline
synaptic transmission for at least 20 min, one of the two Schaffer
collateral input pathways was stimulated with a theta-burst paradigm
that was paired, with a small temporal offset, with an identical theta-
burst paradigm applied to the alveus of CA1 (pTBS; Fig. 1A and B).
The rationale for this pairing paradigm was to elicit synaptic events
coinciding with backpropagating action potentials in the postsynaptic
neuronal population.
pTBS of the Schaffer collateral input⁄alveus induced signiﬁcant
LTP in wild-type mice (potentiation after 45 min: 150 ± 10%,
Student’s t-test, t = 4.0, P < 0.05) as well as Gria1
) ⁄ ) mice
(154 ± 15%, t = 3.6, P < 0.01), whereas no fEPSP slope changes
were observed in the unpaired control pathway (wild-type: 100 ± 5%,
t <1 ;Gria1
) ⁄ ): 105 ± 4%, t < 1; Fig. 3A). However, the absence of
an early, rapidly decaying component of potentiation readily distin-
guished LTP in Gria1
) ⁄ ) mice from potentiation in their wild-type
littermates. Despite this difference in the early potentiation, fEPSPs in
both genotypes reached the same level of potentiation 45 min after
induction. In order to compare the time course and amount of pTBS-
induced potentiation in wild-type and Gria1
) ⁄ ) mice, a RM anova
was conducted on the normalised fEPSP slopes immediately
(0–5 min), 15–20 min and 45–50 min after induction in both
genotypes. The anova revealed no main effect of genotype (F < 1),
a main effect of time (F2,24 = 6.5, P < 0.05), and a signiﬁcant
interaction of time and genotype (F2,24 = 8.9, P < 0.01). A post hoc
analysis of the simple main effects of genotype at each individual time
point conﬁrmed that the amount of potentiation in Gria1
) ⁄ ) and wild-
type mice differed immediately after pTBS (F1,12 = 12.7, P < 0.001),
but not 15 min or 45 min after induction (both F < 1).
Although pTBS-induced LTP was pathway speciﬁc when observed
with extracellular ﬁeld recordings, the intracellular theta-burst stim-
ulation originally used to induce GluA1-independent potentiation not
only potentiated the EPSP in the paired pathway, but also caused a
signiﬁcant increase of EPSP amplitude in the control pathway
(Hoffman et al., 2002). Therefore, in order to test whether the
GluA1-independent potentiation we observed with ﬁeld recordings is
a pathway-speciﬁc form of LTP also at the single-cell level, we
recorded from individual pyramidal neurons in whole-cell mode and
applied pTBS under experimental conditions identical to those
described above for ﬁeld recordings.
Firing patterns and post hoc biocytin labelling conﬁrmed that the
cells we recorded from were pyramidal neurons. As observed with
ﬁeld recordings, pTBS of the Schaffer collaterals⁄alveus induced
similar amounts of LTP in CA1 pyramidal cells of Gria1
) ⁄ ) mice
(potentiation after 40 min: 181 ± 27%; Student’s t-test: t = 3.9,
P < 0.05) and their wild-type littermates (potentiation after 40 min:
184 ± 27%; t = 3.4, P < 0.05; Fig. 3B). In both genotypes, LTP was
observed only in the paired pathway, with no signiﬁcant change in the
control pathway in either wild-type (85 ± 17%, t <1 )o rGria1
) ⁄ )
mice (111 ± 5%, t < 1). Intracellular, GluA1-independent LTP
showed the same characteristic lack of an initial, rapidly decaying
potentiation as LTP recorded in the ﬁeld, and eventually reached the
same level as intracellular LTP in wild-type mice. A RM anova
comparing EPSP potentiation in the two genotypes immediately, and
40 min after induction, revealed no main effect of genotype or time
(all F < 2.5, P > 0.10), but a signiﬁcant genotype by time interaction
(F1,8 = 25.8, P < 0.005). A post hoc analysis of simple main effects
showed a signiﬁcant difference in the magnitude of potentiation
between wild-type and Gria1
) ⁄ ) mice immediately after pTBS
(F1,8 = 6.1, P < 0.05), but not 40 min after induction (F < 1.4,
P > 0.20). Hence, both single-cell and ﬁeld recordings show that the
GluA1 subunit is not obligatory for input-speciﬁc LTP at Schaffer
collateral–CA1 pyramidal cell synapses.
A single weak tetanus is not sufﬁcient to induce
GluA1-independent LTP
Becauseprevious studiesreportedalack ofLTPinadultGria1
) ⁄ ) mice
(Zamanillo et al., 1999; Jensen et al., 2003), we also tested whether a
single 100-Hz tetanus, as used by Zamanillo et al. (1999), would be
sufﬁcient to induce GluA1-independent LTP. Although this weaker
induction paradigm led to small but signiﬁcant LTP in wild-type mice
(potentiation 45 min after induction: 135 ± 13%, t = 2.65, P < 0.05),
no signiﬁcant potentiation developed in Gria1
) ⁄ ) mice (105 ± 10%,
t < 1; Fig.4),whichsuggeststhat GluA1-independent LTP andGluA1-
dependent potentiation have distinct induction properties.
PPRs give no evidence for a presynaptic expression
mechanism of GluA1-independent LTP
Both pre- and postsynaptic mechanisms can contribute to the
expression of long-lasting changes in synaptic efﬁcacy (see Malenka
& Bear, 2004). Because the GluA1 subunit is important for several
mechanisms implicated in postsynaptic LTP expression (Benke et al.,
1998; Derkach et al., 1999; Hayashi et al., 2000; Shi et al., 2001;
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possible that GluA1-independent LTP could be expressed presynap-
tically. A decrease in the PPR after LTP induction is commonly used
to argue for the recruitment of presynaptic expression mechanism(s),
because a presynaptic expression mechanism mediated by an
increased probability of presynaptic transmitter release would leave
less capacity for paired-pulse facilitation (McNaughton, 1982; Zucker
& Regehr, 2002). However, neither GluA1-independent LTP nor LTP
in wild-type mice was accompanied by a change in PPR (Gria1
) ⁄ ):
140 ± 4% before pTBS, 141 ± 9% 45 min after pTBS; wild-type:
143 ± 4% before pTBS, 138 ± 5% 45 min after pTBS, RM anova all
F < 1). Thus, analysis of PPR provides no evidence for a presynaptic
locus of expression of GluA1-independent LTP at hippocampal CA3–
CA1 synapses.
The induction of GluA1-independent LTP requires activation
of GluN2B subunit-containing NMDAR
Because GluA1-independent LTP can be induced with a theta-burst
pairing paradigm, but does not occur after a single weak tetanus, we
investigated whether distinct NMDAR subunits are involved in the
Fig. 4. A single weak tetanus is not sufﬁcient to induce LTP in Gria1
) ⁄ )
mice. (A) Mean potentiation in wild-type (n = 6) and Gria1
) ⁄ ) mice (n =5 )
after a single tetanus to the Schaffer collateral pathway. Data are presented as
mean ± SEM. (B) Normalised ﬁeld excitatory postsynaptic potential (fEPSP)
slope in each individual slice 45 min after the tetanus in wild-type (circles) and
Gria1
) ⁄ ) mice (squares).
Fig. 3. Hippocampal CA3–CA1 LTP in Gria1
) ⁄ ) and wild-type mice. (A) Mean paired theta-burst stimulation (pTBS)-induced LTP of ﬁeld excitatory postsynaptic
potentials (fEPSPs) in (i) wild-type (n = 6) and (ii) Gria1
) ⁄ ) mice (n = 8). The insets show example traces of the paired (left) and control pathways (right) before
(grey) and 45 min after pTBS (black). (iii) Normalised fEPSP slope in each individual slice 45 min after pTBS in paired (open symbols) and control pathway (ﬁlled
symbols). (B) The same paradigm induced input-speciﬁc LTP of EPSPs in individual CA1 pyramidal neurons of both (i) wild-type (n = 4), and (ii) Gria1
) ⁄ ) mice
(n = 5). The insets show example traces of the paired (left) and control pathways (right) before (grey) and 45 min after pTBS (black). (iii) Normalised EPSP slope in
each individual cell 45 min after pTBS.
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synapses, NMDAR form GluN1⁄GluN2A, GluN1⁄GluN2B and
GluN1⁄GluN2A⁄GluN2B heteromers (Monyer et al., 1994; Cull-
Candy et al., 2001; Ko ¨hr, 2006), and recent evidence suggests that
GluN2A and GluN2B subunits are linked to distinct intracellular
signalling cascades (Liu et al., 2004; Barria & Malinow, 2005; Kim
et al., 2005).
First, we tested whether pTBS-induced, GluA1-independent LTP
and LTP in wild-type mice are similarly affected by the general
NMDAR antagonist CPP (30 lm). As previously described by
Hoffman et al. (2002) for the intracellular GluA1-independent LTP,
the inhibition of NMDAR completely abolished the induction of
GluA1-independent potentiation by an extracellular pTBS paradigm,
as well as LTP in wild-type mice (Fig. 5A). A RM anova with drug
as a between-subjects factor (CPP vs. control) and time as a within-
subjects factor (0–5 min and 45–50 min after pTBS) for each
genotype revealed a main effect of drug on LTP, both in Gria1
) ⁄ )
mice (F1,10 = 49.2, P < 0.005, drug by time interaction, F1,10 = 6.9,
P < 0.05), and in wild-type littermate controls (F1,14 = 21.4,
P < 0.001, main effect of time, F1,14 = 8.3, P < 0.05, no further
interactions, all F <1 ) , which shows that NMDAR activation
is necessary, both for the induction of the early, decaying phase
of potentiation in wild-type mice and for GluA1-independent
potentiation.
To target GluN2B-containing NMDAR, we used the GluN2B
subunit-selective compound Ro 25-6981 (Fischer et al., 1997).
Superfusion of 0.5 lm Ro 25-6981 for at least 1 h prior to pTBS
had no effect on the induction of LTP in wild-type mice, and in
particular did not affect the early, rapidly decaying phase [Fig. 4B; RM
anova with drug condition (Ro 25-6981 vs. control) as a between-
subjects factor and time (0–5 min and 45–50 min after pTBS) as a
within-subject factor, no effect of drug or interactions involving drug,
all F < 1]. In contrast, Ro 25-6981 strongly reduced GluA1-indepen-
dent LTP (Fig. 5B; main effect of drug, F1,24 = 27.7, P < 0.005, drug
by time interaction, F1,24 = 7.9, P<0.001). Thus, induction of LTP
requires the activation of GluN2B-containing NMDAR in Gria1
) ⁄ )
mice, whereas the GluN2B subunit does not appear to be required
when GluA1 is present.
In the next set of experiments, slices were treated with the GluN2A
subunit-preferring NMDAR antagonist NVP-AAM077 (Auberson
et al., 2002). Because the selective action of NVP-AAM077 is
concentration-dependent (Berberich et al., 2005; Neyton & Paoletti,
2006), NVP-AAM077 was applied at two concentrations, 50 and
400 nm. In HEK293 cells expressing either GluN1⁄GluN2A- or
GluN1⁄GluN2B-type rodent NMDAR, 50 nm NVP-AAM077 inhibits
77% of GluN2A-mediated NMDA receptor currents and 27% of
GluN2B-mediated NMDA receptor currents, whereas 400 nm NVP-
AAM077 blocks 97% of the GluN2A-mediated currents and 67% of
GluN2B-mediated currents (Berberich et al., 2005). When applied to
the superfusate for at least 1 h prior to pTBS, 50 nm NVP-AAM077
had no overall effect on LTP in either wild-type or Gria1
) ⁄ ) mice (all
F < 1, see overall RM anova results below). Although not strictly
appropriate in the absence of a signiﬁcant drug by time interaction
(Howell, 1997), a separate t-test comparing the early, possibly GluA1-
dependent component of potentiation in wild-type mice with and
without NVP-AAM077 revealed a signiﬁcant effect of drug (t = 3.8,
P < 0.05). NVP-AAM077 (400 nm) in the superfusate entirely
prevented the induction of LTP in both genotypes (Fig. 5C). A RM
anova with drug (0, 50 and 400 nm NVP-AAM077) as a between-
subjects factor and time (0–5 min and 45–50 min after pTBS) as a
within-subject factor for each genotype revealed a main effect of drug
on LTP in Gria1
) ⁄ ) mice (F2,18 = 5.8, P < 0.001, no further effects or
interactions, all F <2 ,P > 0.2) and wild-type mice (F2,24 = 12.6,
P < 0.001; main effect of time, F1,24 = 10.7, P < 0.005; no interac-
tions, all F < 2). A post hoc comparison of the effect of 50 nm NVP-
AAM077 returned no signiﬁcant effect of 50 nm NVP-AAM077
(Gria1
) ⁄ ): F <1 , P > 0.1; wild-type: F <1 , P > 0.1), and no
signiﬁcant drug by time interaction (Gria1
) ⁄ ): F <1 , P > 0.2;
wild-type: F <1 , P > 0.1) in either genotype. In contrast, a
post hoc comparison of the effect of 400 nm NVP-AAM077 revealed
a signiﬁcant effect on LTP in wild-type (F1,24 = 12.6, P < 0.001) and
Gria1
) ⁄ ) mice (F1,18 = 5.8, P < 0.05).
Thus, only the early, possibly GluA1-dependent component of
potentiation in wild-type mice was sensitive to NVP-AAM077 at low
concentrations. The limited selectivity of NVP-AAM077 at higher
concentrations prevented us from reaching a deﬁnitive conclusion
about the contribution of GluN2A-containing NMDAR to induction of
LTP in either genotype.
GluA1-independent LTP requires CaM kinase
Downstream of NMDAR activation, a transient rise in intracellular
Ca
2+ levels is thought to be important for LTP induction (Lynch et al.,
1983; Collingridge et al., 1992; Raymond & Redman, 2002).
The enzyme CaM kinase II (CaMKII) acts as a Ca
2+ sensor in the
postsynaptic spine and is essential for LTP in wild-type mice
(Malinow et al., 1988, 1989; Silva et al., 1992). GluA1, which can
be phosphorylated by CaMKII on the S831 residue (Barria et al.,
1997; Lee et al., 2000), is among the many target proteins of CaMKII
that have been implicated in synaptic plasticity. We therefore asked
whether a CaM kinase is still required for LTP when GluA1 is absent.
The CaM kinase inhibitor KN-62 (10 lm) was applied for at least 2 h
prior to pTBS, and had no effect on basal synaptic transmission in
either genotype (Fig. 6D; RM anova F <1 , P > 0.3 for both
genotypes). It completely abolished LTP in wild-type mice, and also
attenuated LTP in their Gria1
) ⁄ ) littermates (Fig. 6A). A RM anova
with drug (KN-62 vs. control) as a between-subjects factor and time
(0–5 min and 45–50 min after pTBS) as a within-subject factor
returned a main effect of drug on LTP in Gria1
) ⁄ ) (F1,11 = 29.7,
P < 0.001, no further effects or interactions, all F < 1.9, P > 0.2) and
wild-type mice (F1,11 = 13.1, P < 0.005, main effect of time,
F1,11 = 8.9, P < 0.05, no interactions, all F < 1). Thus, CaM kinase
appears to be necessary for the induction of LTP regardless of whether
or not the GluA1 subunit is present.
GluA1-independent LTP is mediated by a pathway involving
nNOS and PKC
Although research on the expression mechanisms of LTP has focused
mainly on the activity-driven synaptic insertion of GluA1 (Shi et al.,
2001), recent data from cultured cerebellar and hippocampal neurons
have revealed a nitric oxide and N-ethylmaleimide-sensitive factor
(NSF)-dependent pathway that leads to an increase in synaptic GluA2
subunits (Huang et al., 2005; Sossa et al., 2006, 2007). In order to
assess whether this, or a similar, pathway mediates the GluA1-
independent form of LTP in Gria1
) ⁄ ) mice, extracellular ﬁeld
recordings were performed in the presence of a potent, membrane-
permeable inhibitor of nNOS, 100 lm nNOS inhibitor I. This inhibitor
had no effect on basal synaptic transmission in either genotype
(Fig. 6D; RM anovas, F <1 ,P > 0.2 for both genotypes) or on the
amplitude of pTBS-induced LTP in wild-type mice [Fig. 6B; RM
anova with drug (nNOS inhibitor I vs. control) as a between-subjects
factor and time (0–5 min and 45–50 min after pTBS) as a within-
subject factor: main effect of time, F1,15 = 7.0, P < 0.05, no main
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signiﬁcantly reduced the magnitude of potentiation in Gria1
) ⁄ ) mice
[Fig. 6B; RM anova with drug (nNOS inhibitor I vs. control) as a
between-subjects factor and time (0–5 min and 45–50 min after
pTBS) as a within-subject factor, main effect of drug, F1,18 = 5.7,
P < 0.05, no further effects or interactions, all F <2 , P > 0.1].
Similar results were obtained with a second nNOS inhibitor, L-VNIO
(0.2 lm), which had no signiﬁcant effect on the ﬁrst 60 min of
potentiation in wild-type mice (Fig. 6B; RM anova, no main effect of
drug or interactions, all F <2 ,P > 0.1), but signiﬁcantly reduced LTP
in Gria1
) ⁄ ) animals [Fig. 6B; RM anova with drug (L-VNIO vs.
control) as a between-subjects factor and time (0–5 min and
45–50 min after pTBS) as a within-subject factor, main effect of
drug, F1,9 = 3.9, P < 0.05, no further effects or interactions, all F <1 ,
Fig. 5. GluA1-independent long-term potentiation (LTP) requires activation of GluN2B-containing NMDA receptors. (A) The NMDAR antagonist 3-(R-2-
carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP) blocked pTBS-induced LTP in wild-type (n = 7, control n = 9) and Gria1
) ⁄ ) mice (n = 5, control n = 7).
(B) The GluN2B subunit-selective NMDAR antagonist (aR,bS)-a-(5-hydroxyphenyl)-b-methyl-4-(phenylmethyl)-1-piperidinepropanol (Ro 25-6981) had no effect
on LTP in wild-type mice (n = 9, control n = 15), but attenuated LTP in Gria1
) ⁄ ) mice (n = 15, control n = 11). (C) (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-
dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl-phosphonic acid (NVP-AAM077) (50 nm) had no signiﬁcant effect on either GluA1-independent LTP (n =6 ,
control n = 6) or LTP in wild-type mice (n = 12, control n = 8). NVP-AAM077 (400 nm) attenuated both GluA1-independent LTP (n = 9) and LTP in wild-type
mice (n = 7). Data are presented as mean ± SEM. fEPSP, ﬁeld excitatory postsynaptic potential.
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control n = 4) and wild-type LTP (n = 7, control n = 6) are both attenuated by the CaM kinase inhibitor 4-[(2S)-2-[(5-isoquinolinylsulphonyl)methylamino]-3-oxo-
3-(4-phenyl-1-piperazinyl)propyl] phenylisoquinolinesulphonic acid ester (KN-62). (B) nNOS inhibitor I and L-VNIO had no effect on the early potentiation in wild-
type mice (left, nNOSi I: n = 12; L-VNIO: n = 5; control: n = 5), whereas they strongly reduced GluA1-independent LTP (right, nNOSi I: n = 14; L-VNIO: n =5 ;
control: n = 6). (C) Chelerythrine (2 lm) reduced GluA1-independent LTP (right, n = 8, control n = 9), and the later phase of potentiation in wild-type mice (left,
n = 13, control n = 10). (D) Stimulus–response curves before and 3 h after application of CaM kinase, nNOS and PKC inhibitors in wild-type (left, KN-62: n =8 ;
nNOSi I: n = 9; chelerythrine: n = 7) and Gria1
) ⁄ ) mice (right, KN-62: n = 12; nNOSi I: n = 7; chelerythrine: n = 9). fEPSP, ﬁeld excitatory postsynaptic potential.
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induction of GluA1-independent LTP, which supports the hypothesis
that this form of LTP might be mediated by an insertion of GluA2-
containing AMPAR via a regulated nNOS and possibly NSF-
dependent pathway (Sossa et al., 2006, 2007).
PKC is another protein involved in the synaptic trafﬁcking of both
GluA1 (Boehm et al., 2006) and GluA2 AMPAR subunits (Daw et al.,
2000; Perez et al., 2001), and particularly the PKMf isoform plays an
important role in the later phases of LTP in wild-type mice (Ling et al.,
2006; Yao et al., 2008). We therefore tested whether PKC activity is
required for the GluA1-independent form of LTP. Inhibition of PKC
with chelerythrine (2 lm), an inhibitor that, at low concentrations,
shows a preference for PKMf over other PKC isoforms (Ling et al.,
2002), had no effect on basal synaptic transmission in either wild-type
or Gria1
) ⁄ ) mice (Fig. 6D; RM anovas, F <1 ,P > 0.2 for both
genotypes). In wild-type mice, chelerythrine had no effect on the
magnitude of the initial potentiation immediately after pTBS, but
signiﬁcantly reduced the magnitude of LTP 45 min after induction
(Fig. 6C). A RM anova with drug (chelerythrine vs. control) as a
between-subjects factor and time (0–5 min and 45–50 min after
induction) as a within-subject factor returned no effect of drug (F < 1),
but a signiﬁcant drug by time interaction (F1,21 = 9.5, P < 0.005).
A post hoc simple main effects analysis of the effect of chelerythrine
at each time point conﬁrmed that there was no effect on the early,
rapidly decaying potentiation in wild-type mice (F < 1). In contrast,
LTP 45 min after induction was signiﬁcantly reduced (F1,21 = 7.1,
P < 0.05). In Gria1
) ⁄ ) mice, chelerythrine (2 lm) strongly attenuated
the overall level of potentiation [Fig. 6C; RM anova with drug
(chelerythrine vs. control) as a between-subjects factor and time
(0–5 min and 45–50 min after pTBS) as a within-subject factor, main
effect of drug, F1,15 = 4.9, P < 0.05, no further effects or interactions,
all F < 3.4, P > 0.09]. Hence, both GluA1-independent LTP and the
later phase of conventional LTP in wild-type mice require PKC,
possibly the PKMf isoform.
Discussion
The role of GluA1 in LTP
It is well established that the GluA1 subunit is important for the
expression of LTP. Phosphorylation of GluA1 has been shown to
increase the conductance of AMPAR (Benke et al., 1998; Derkach
et al., 1999), and the interaction of trafﬁcking proteins and kinases
with GluA1 regulates the activity-dependent surface expression of
AMPAR (Hayashi et al., 2000; Lu et al., 2001; Shi et al., 2001;
Piccini & Malinow, 2002). Furthermore, Zamanillo et al. (1999)
previously reported that Gria1
) ⁄ ) mice did not express CA3–CA1
LTP. However, this view has been challenged by Hoffman et al.
(2002), who provided initial evidence that a GluA1-independent form
of potentiation can be expressed in these animals, when an
intracellular, paired theta-burst induction protocol is used. Whereas
the induction paradigm used by Hoffman et al. (2002) not only
potentiated EPSPs in the paired pathway but also the unpaired control
pathway, and the resulting, GluA1-independent potentiation devel-
oped gradually over 30 min, we have demonstrated here that
extracellular pTBS can induce robust, input-speciﬁc, GluA1-indepen-
dent LTP that is rapidly established within 5–10 min. However,
GluA1-independent LTP could not be induced with a single weak
tetanus (also see Zamanillo et al., 1999; Jensen et al., 2003), and
lacks the initial, rapidly decaying potentiation seen in wild-type mice.
Thus, synaptic potentiation at CA3–CA1 synapses appears to
comprise a rapidly decaying, GluA1-dependent potentiation, and a
more persistent, GluA1-independent potentiation that requires a
stronger induction paradigm. Our initial ﬁndings raise the question
about the extent to which induction and expression mechanisms of
these two forms of potentiation are distinct or shared. We have
established GluN2B-containing NMDAR, CaM kinase, PKC and
nNOS as part of the signalling cascade that mediates GluA1-
independent LTP. Of those, only CaM kinase was also required for the
induction of the early, rapidly decaying, probably GluA1-dependent
form of potentiation in wild-type mice. Although our ﬁndings are not
sufﬁcient to explain how GluA1-independent LTP is ﬁnally
expressed, CaMKII, nNOS and PKC are known to regulate the
activity-dependent, synaptic expression of AMPAR by interacting
with the GluA2 subunit (Daw et al., 2000; Gardner et al., 2005; Oh &
Derkach, 2005; Lin & Huganir, 2007; Yao et al., 2008).
GluA1-independent LTP requires GluN2B-containing NMDAR
Both GluA1-independent LTP and LTP in wild-type mice are
NMDAR dependent. Unlike LTP in wild-type mice, GluA1-indepen-
dent LTP was strongly attenuated by the GluN2B subunit-selective
NMDAR antagonist Ro 25-6981. Because GluN2B-containing
NMDAR are preferentially, although not exclusively, located extra-
synaptically (Stocca & Vicini, 1998; Tovar & Westbrook, 1999;
Steigerwald et al., 2000), and a single weak tetanus failed to induce
LTP in Gria1
) ⁄ ) mice, the induction of GluA1-independent LTP
might require a more global Ca
2+ signal. Consistent with this
possibility, Hoffman et al. (2002) found that the early, possibly
GluA1-dependent phase of potentiation and the later, possibly GluA1-
independent phase of LTP in wild-type mice are differentially sensitive
to internal Ca
2+ buffers. Alternatively, or additionally, the relative
synaptic GluN2B⁄GluN2A subunit composition might be different in
the Gria1
) ⁄ ) mice, as has recently been described in Kv4.2
) ⁄ ) mice
(Jung et al., 2008).
Although we show an important role of GluN2B-containing
NMDAR in the induction of GluA1-independent LTP, the contribution
of GluN2A-containing NMDAR remains uncertain. NVP-AAM077
(50 nm) had no effect on LTP in Gria1
) ⁄ ) mice, but signiﬁcantly
reduced the early potentiation in wild-type mice, suggesting a more
important role of GluN2A in this early, possibly GluA1-dependent
potentiation. At the higher concentration used (400 nm), NVP-
AAM077 blocked LTP in both genotypes, but does not distinguish
between GluN2A- and GluN2B-containing receptors (Berberich et al.,
2005; Neyton & Paoletti, 2006).
Downstream signalling in GluA1-independent LTP: CaM kinase,
PKC and nNOS
The CaM kinase inhibitor KN-62 blocked GluA1-independent LTP
and both the early and the later phases of LTP in wild-type mice. The
necessity of CaMKII for at least the early phases of conventional LTP
is well established (see Lisman et al., 2002), but one of the main
CaMKII target proteins implicated in this process is the GluA1 subunit
(Barria et al., 1997; Benke et al., 1998; Lee et al., 2000, 2003). Our
ﬁndings suggest that CaM kinase target proteins other than GluA1 are
involved in the induction and⁄or expression of sustained GluA1-
independent LTP. Interestingly, an interaction of CaMKII with the
GluN2B NMDAR subunit has been reported to be necessary for
pairing-induced LTP in wild-type mice (Barria & Malinow, 2005).
However, because KN-62 inhibits other CaM kinases in addition to
CaMKII (Enslen et al., 1994), we cannot attribute the effect of KN-62
to inhibition of CaMKII (Wayman et al., 2008), and it is possible that
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mediated by distinct members of the CaM kinase family.
We also showed that GluA1-independent LTP is attenuated by
chelerythrine, a potent, cell-permeable PKC inhibitor that binds to the
catalytic domain of PKC. Postsynaptic PKC is activated following
strong NMDAR activation and release of Ca
2+ from intracellular
stores, experimentally achieved by stronger, repetitive LTP induction
paradigms (Bliss & Collingridge, 1993; Raymond, 2007). Activated
PKC has been shown to regulate synaptic AMPAR trafﬁcking by
phosphorylation of GluA1 (Boehm et al., 2006) and AMPAR surface
expression by phosphorylation of GluA2 (Daw et al., 2000; Gardner
et al., 2005; Lin & Huganir, 2007) and⁄or PICK1, a GluA2-linked
trafﬁcking protein (Staudinger et al., 1995, 1997; Perez et al., 2001).
Furthermore, the PKC isoform PKMf increases synaptic AMPAR and
excitatory synaptic transmission (Ling et al., 2006), probably by an
NSF⁄GluA2-dependent mechanism that was recently found to
maintain late-phase LTP through persistent trafﬁcking of AMPAR to
the synapse (Yao et al., 2008). Thus, PKC-regulated synaptic
trafﬁcking of GluA2 might contribute to GluA1-independent LTP.
Finally, we showed that GluA1-independent LTP is attenuated by the
nNOS inhibitors nNOSi I and V-LNIO. Because the exact intracellular
concentrations of these drugs under our experimental conditions are
unknown, we cannot rule out the possibility that the inhibitors also
affected other NOS isoforms. Indeed, it was recently reported that
endothelialNOS (eNOS) is also involved ina GluA1-independent form
of LTP (Phillips et al., 2008). In wild-type mice, nNOS is known to
produce nitric oxide upon NMDAR activation (Bredt & Snyder, 1989;
Garthwaite et al., 1989; Brenman et al., 1996; Brenman & Bredt,
1997), and nitric oxide can S-nitrosylate NSF (Huang et al., 2005),
another protein implicated in GluA2 trafﬁcking. S-nitrosylation of NSF
results in an increased surface expression of GluA2-containing
AMPAR in cultured cerebellar and hippocampal neurons (Huang
et al., 2005; Sossa et al., 2006, 2007). Indeed, Kakegawa & Yuzaki
(2005) showed that such a mechanism could underlie GluA1-
independent LTP at cerebellar parallel ﬁbre–Purkinje cell synapses.
Although nNOS inhibitor I in our hands did not affect LTP in wild-type
mice, a previous study reported that nNOS inhibitors produce a major
loss of particularly the later phases of LTP (Hopper & Garthwaite,
2006). Taken together with the evidence that GluA1-independent LTP
might also require PKMf, it is possible that GluA1-independent
mechanisms mediate or maintain later phases of LTP in wild-type mice.
Reduced synaptic transmission in Gria1
) ⁄ ) mice
Field excitatory synaptic transmission in Gria1
) ⁄ ) mice was reduced
relative to wild-type mice. Given the evidence that AMPAR in CA1
pyramidal neurons of wild-type mice mainly consist of GluA1⁄GluA2
heteromers, fewer GluA2⁄GluA3 complexes and some GluA1 homo-
mers (Wenthold et al., 1996), the observed reduction in excitatory
synaptic transmission in Gria1
) ⁄ ) mice is not surprising. On the other
hand, the majority of AMPAR in CA1 pyramidal neurons are found at
extrasynaptic sites (Shi et al., 1999), so GluA1-lacking AMPAR might
beabletocompensateforthemissingGluA1-containing AMPARatthe
synapse.Indeed, Zamanillo et al. (1999) reported that AMPAR currents
inGria1
) ⁄ )micearestronglyreducedatthesoma,butlargelyunaltered
at synaptic sites on the proximal dendrites, which seems to be at odds
with our ﬁndings. While we cannot explain this apparent discrepancy, a
morerecentstudyshowedthatAMPAR-mediatedcurrentsatmoredistal
dendritic sites in Gria1
) ⁄ ) mice are prominently reduced (Andrasfalvy
et al., 2003), and Jensen et al. (2003) reported a strongly reduced
synaptic AMPA⁄NMDA current ratio in adult (>P42) Gria1
) ⁄ ) mice.
Does GluA1-independent LTP exist in wild-type mice?
A common problem of working with genetically modiﬁed mice is that
deletion of a gene might alter developmental processes. Cellular,
transcriptional and⁄or nuclear plasticity might compensate for the lack
of a gene by recruiting mechanisms⁄proteins⁄genes not normally used
for a function, or by developing entirely new mechanisms. Thus, the
GluA1-independent, GluN2B-, nNOS- and PKC-dependent form of
LTP that we describe in Gria1
) ⁄ ) mice might be the result of altered
development or the recruitment of GluA1-independent mechanisms
not present in wild-type mice. However, similar cellular signalling
cascades involving nitric oxide and PKC have previously been shown
to mediate AMPAR exocytosis in cultured hippocampal neurons
(Sossa et al., 2007) and mediate activity-regulated GluA2 surface
expression in wild-type animals (Daw et al., 2000; Hayashi et al.,
2000; Passafaro et al., 2001; Yao et al., 2008). Whether GluA1-
dependent and GluA1-independent mechanisms in wild-type mice are
really as separable as our data from Gria1
) ⁄ ) mice suggest remains to
be investigated. Because most AMPAR at hippocampal synapses of
wild-type mice consist of either GluA1⁄GluA2 or GluA2⁄GluA3
heteromers (Wenthold et al., 1996), an interaction of both GluA1- and
GluA2-linked (and possibly GluA3-linked) trafﬁcking⁄anchoring
cascades is likely to determine the synaptic expression and mainte-
nance of these receptors, and therefore the ultimate magnitude and
persistence of LTP. Hence, GluA1-independent LTP as uncovered in
Gria1
) ⁄ ) mice might be redundant for some but not all phases of LTP
in wild-type mice, which would explain why the ﬁrst hour of LTP in
wild-type mice neither required GluN2B nor nNOS.
Interestingly, the dissociation of GluA1-dependent and GluA1-
independent potentiation is matched by a dissociation of two types of
hippocampus-dependent spatial memory: the GluA1 subunit is
necessary for spatial working memory, whereas the gradual acquisition
of spatial reference memory tasks is GluA1-independent (Reisel et al.,
2002; Schmitt et al., 2003; Sanderson et al., 2007). In neither case
(plasticity or behaviour) is the short-term process required for the
long-term process to manifest. This highlights the importance of
distinguishing between different plasticity mechanisms when address-
ing the relationship between synaptic plasticity and memory.
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